From 'Heart vs. Brain' to 'Heart and Brain Together': PUMCH Publishes Landmark Evidence on Infective Endocarditis Surgery
The Deadliest Catch-22 in Cardiac Surgery — Finally Resolved
Imagine this scenario: a patient has a life-threatening heart valve infection. The infected tissue is spewing bacteria-laden debris into the bloodstream with every heartbeat. Surgery to remove the infection is urgent — but the same debris has already caused a stroke. Operating on the heart requires blood thinners that could turn a small brain bleed into a fatal hemorrhage.
Operate on the heart? Risk killing the brain. Wait to protect the brain? Risk losing the heart.
For decades, this dilemma has haunted every cardiac surgeon who treats infective endocarditis (IE) with neurological complications — a scenario affecting 20%-40% of all IE patients, with mortality rates as high as 45%.
Now, a landmark study from Peking Union Medical College Hospital (PUMCH) has provided the clearest evidence yet on how to navigate this impossible choice.
The Research
The study, led by PUMCH Cardiac Surgery Chief Director Zheng Jun and Deputy Director Zhang Chaoji, was published in the Journal of the American Heart Association (JAHA) — a prestigious journal ranked in the Chinese Academy of Sciences' Zone 1 (top tier).
The team analyzed 663 patients with left-sided infective endocarditis treated at PUMCH between December 2012 and December 2024, of whom 204 had pre-operative neurological complications — making this one of the largest single-center IE datasets in the world.
The Key Findings
Four critical discoveries emerged that change how cardiac surgeons should approach IE with brain complications:
Finding 1: Stroke without hemorrhagic conversion → Operate promptly
Patients who suffered cerebral infarction (ischemic stroke) without subsequent bleeding into the damaged brain tissue can safely undergo cardiac surgery without increased mortality risk. Waiting provides no benefit and allows the heart infection to worsen.
Finding 2: Stroke with hemorrhagic conversion → Wait 14 days
For patients whose stroke has converted to hemorrhagic (bleeding into the infarct zone), surgery within 7 days carries significantly elevated risk. However, by day 14, the surgical risk drops substantially — providing a clear timeline for operative planning.
Finding 3: Biological valves reduce brain bleeding risk
Patients who received biological (tissue) valve replacements required lower-intensity anticoagulation post-operatively compared to mechanical valves. This reduced the risk of intracranial hemorrhage — a critical advantage for patients whose brains are already vulnerable.
Finding 4: Three independent risk factors identified
| Risk Factor | Clinical Significance |
|---|---|
| Peripheral vascular disease | Indicates widespread arterial vulnerability; higher embolic risk |
| Mitral valve infection | Mitral vegetations have the highest embolic potential |
| Staphylococcus aureus | Most aggressive pathogen; rapid tissue destruction |
The "Heart-Brain Co-Treatment" Framework
Based on these findings, the PUMCH team established a five-tier risk stratification system — the "Heart-Brain Co-Treatment" concept — that matches each patient's neurological status to an optimal surgical window and valve strategy.
The results speak for themselves:
- Mortality among IE patients with neurological complications: reduced to 8.8% (compared to historical rates of 20-45%)
- Over 80% of patients with brain injury achieved good neurological recovery after surgery
These outcomes place PUMCH among the world's best-performing centers for this notoriously difficult condition.
Why This Matters for International Patients
Infective endocarditis is a global problem. It can strike anyone — from young adults with congenital heart defects to elderly patients with prosthetic valves, to IV drug users, to patients with weakened immune systems. When neurological complications develop, patients need a surgical team that understands exactly when and how to intervene.
Many hospitals around the world still use outdated guidelines that recommend blanket delays of 2-4 weeks after any neurological event. PUMCH's research demonstrates that this one-size-fits-all approach is both unnecessarily dangerous (for patients who should be operated sooner) and insufficiently cautious (for patients who need longer recovery).
Cardiac Surgery Cost: China vs Western Countries
| Procedure | China (PUMCH) | United States |
|---|---|---|
| Valve replacement for infective endocarditis | $18,000 - $35,000 | $100,000 - $250,000 |
| Biological valve replacement | $20,000 - $38,000 | $80,000 - $200,000 |
| Mechanical valve replacement | $15,000 - $30,000 | $70,000 - $180,000 |
| Cardiac ICU (per day) | $500 - $1,200 | $5,000 - $15,000 |
| Post-operative neuro rehabilitation (per week) | $1,500 - $3,000 | $10,000 - $20,000 |
China prices include surgery, valve prosthesis, hospital stay, ICU, and initial post-operative monitoring.
Who Should Consider IE Treatment at PUMCH?
This level of specialized care is relevant for patients with:
- Active infective endocarditis — Especially with large vegetations, embolic events, or heart failure
- IE with stroke or brain abscess — The exact clinical scenario this research addresses
- Prosthetic valve endocarditis — Reinfection of a previously replaced valve
- Failed antibiotic therapy — Persistent bacteremia despite appropriate medication
- Complex multi-valve disease — Infection involving more than one heart valve
About PUMCH Cardiac Surgery
PUMCH's cardiac surgery department, led by Chief Director Zheng Jun, is among the most respected in China:
- Ranked #1 hospital in China for 14 consecutive years — PUMCH represents the pinnacle of Chinese medicine
- One of the largest IE surgical databases in the world — 663+ cases over 12 years
- Research published in top-tier international journals including JAHA (American Heart Association)
- Multidisciplinary collaboration with neurology, neurosurgery, and infectious disease for every complex IE case
- Located in central Beijing, with established international patient services
Frequently Asked Questions
What is infective endocarditis?
Infective endocarditis is a bacterial or fungal infection of the heart valves or inner lining of the heart. Bacteria attach to damaged or abnormal valve tissue, forming clusters called vegetations that can destroy the valve, cause heart failure, and send infected fragments to the brain and other organs.
How do I know if I need surgery for IE?
Surgery is typically recommended for IE patients with heart failure, uncontrolled infection despite antibiotics, large vegetations (>10mm), embolic events, or prosthetic valve involvement. PUMCH's team can review your case and provide a treatment recommendation within 48 hours.
Can I travel to China if I already had a stroke from IE?
Yes, but timing depends on the type and severity of the neurological event. PUMCH's research provides the exact timing framework. Our team can coordinate with the PUMCH cardiac surgery department to determine the optimal travel and surgery window for your specific situation.
Facing infective endocarditis or complex valve disease? Request a free cardiac surgery consultation →
